Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6204363

Title:Stem cell factor
Inventors:Zsebo, Krisztina M.; Thousand Oaks, CA, USA
Bosselman, Robert A.; Thousand Oaks, CA, USA
Suggs, Sidney V.; Newbury Park, CA, USA
Martin, Francis H.; Thousand Oaks, CA, USA
Summary:Described herein are novel stem cell factor polypeptides and their analoguess. The invention relates to the capacity of such polypeptides and their analogues to stimulate the growth of early hematopoietic progenitor cells. Further disclosed are methods of production, pharmaceutical compositions and therapeutic applications in the treatment of blood disorders such as aplastic anemia, carcinoma, multiple myeloma, vitiligo, kala azar, and Hodgkin's disease. This invention represents a continuation of other applications filed by the same assignee and inventors.
Abstract:Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6204363
Application Number:US1992000982255
Date Filed:25/11/1992
Date Published:20/03/2001
Assignee:Amgen Inc., Thousand Oaks, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/23/2021